Evolving Role of Bone Biomarkers in Castration-Resistant Prostate Cancer
The preferential metastasis of prostate cancer cells to bone disrupts the process of bone remodeling and results in lesions that cause significant pain and patient morbidity. Although prostate-specific antigen (PSA) is an established biomarker in prostate cancer, it provides only limited informatio...
Main Authors: | Janet E. Brown, Sheryl Sim |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-09-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558610800703 |
Similar Items
-
Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
by: Joelle El-Amm, et al.
Published: (2013-01-01) -
Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer – role of radium-223
by: Mukherji D, et al.
Published: (2014-05-01) -
New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
by: Vincenza Conteduca, et al.
Published: (2021-01-01) -
Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
by: Joelle El-Amm, et al.
Published: (2016-03-01) -
Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
by: Joelle El-Amm, et al.
Published: (2016-01-01)